The Cancer Letter

Inside information on cancer research and drug development

Vol.
18
No.
3
January 17, 1992Jan 17, 1992
Free
DOWNLOAD THE PDF

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

Former NCI Lab Deputy Charged With Two Criminal Counts

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account